Sanofi-Aventis said US sales of anti-thrombotic Lovenox were cut nearly in half by the launch of generic competition, an indication hospitals are showing little hesitation in using the copycat version ...

If you had any lingering doubt that biosimilar drugs will shake up the market for branded meds, here's a remedy. A generic version of Sanofi-Aventis' Lovenox blood thinner--enoxaparin--has surged onto ...

In recommending measures to manage the contamination of heparin-containing medicines, regulators in the European Union have decided that Sanofi-Aventis’ anticoagulant blockbuster Lovenox should stay ...

Sanofi-Aventis, still reeling from the earlier-than-expected launch of a generic version of its Plavix product in the USA (see accompanying story), has filed a lawsuit against Sandoz alleging that the ...

LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...

Lovenox (enoxaparin) is a prescription drug used to prevent or treat certain types of blood clots. Lovenox’s cost may depend on factors such as your dosage, whether you have health insurance, and how ...

Paris, France - Aug 26, 2010 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. District Court for the District of Columbia has denied the Company's request for preliminary ...

Uninsured people who paid out of pocket for the anticoagulant drug Lovenox may be eligible for a payment from a $120 million proposed settlement in a dispute between Nashville General Hospital and two ...